688221.SS · 前沿生物
China A-shares · RS rating 8 · As of 2026-10-14
| Price | 14.19 CNY |
|---|---|
| 1-day change | -3.0% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 13 / 4 / 58 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 5 / 9 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -94.6% |
| Distance from 52-week high | +49.6% |
| Market cap (USD) | $887.9M |